Atlas Trials

Phase II Clinical Study to Evaluate the Efficacy and Safety of XKH001 Injection

Clinical trial NCT07519499 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07519499
Sponsor
Zhejiang Kanova Biopharmaceutical Co., LTD
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
COPD
Start date
2026-04-01
Primary completion
2027-12-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.